SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $102,000 | -62.2% | 11,300 | -50.0% | 0.00% | – |
| Q2 2021 | $270,000 | +365.5% | 22,600 | +391.3% | 0.00% | – |
| Q1 2021 | $58,000 | -85.3% | 4,600 | 0.0% | 0.00% | – |
| Q4 2020 | $395,000 | +797.7% | 4,600 | 0.0% | 0.00% | – |
| Q3 2020 | $44,000 | +4.8% | 4,600 | 0.0% | 0.00% | – |
| Q2 2020 | $42,000 | +180.0% | 4,600 | +100.0% | 0.00% | – |
| Q1 2020 | $15,000 | -21.1% | 2,300 | 0.0% | 0.00% | – |
| Q4 2019 | $19,000 | +850.0% | 2,300 | +1252.9% | 0.00% | – |
| Q3 2019 | $2,000 | -85.7% | 170 | -86.9% | 0.00% | – |
| Q2 2019 | $14,000 | +16.7% | 1,300 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | +20.0% | 1,300 | +52.9% | 0.00% | – |
| Q4 2018 | $10,000 | -28.6% | 850 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | +16.7% | 850 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | +33.3% | 850 | +88.9% | 0.00% | – |
| Q1 2018 | $9,000 | +28.6% | 450 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |